NCT07286266 2025-12-16A Study to Investigate GSK5733584 Compared With Chemotherapy in Participants With Platinum-resistant Ovarian Cancer (BEHOLD-Ovarian01)GlaxoSmithKlinePhase 3 Not yet recruiting450 enrolled